$0.0174
At close: Oct 2, 3:46 PM EDT
Biolase Inc COM PAR $.001 NEW reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Biolase Inc COM PAR $.001 NEW using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.08 | $-0.07 | -14.3 % |
Mar 2024 | 2024-05-13 | $-0.36 | $-0.17 | -111.8 % |
Dec 2023 | 2024-03-21 | $-1.76 | $-2.55 | 31.0 % |
Sep 2023 | 2023-11-09 | $-3.89 | $-1.85 | -110.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $11.56M | $13.49M | -14.3 % |
Mar 2024 | 2024-05-13 | $10.13M | $10.00M | 1.31 % |
Dec 2023 | 2024-03-21 | $13.49M | $13.55M | -0.44 % |
Sep 2023 | 2023-11-09 | $10.92M | $13.96M | -21.8 % |
Biolase Inc COM PAR $.001 NEW (BIOL) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.08, which missed the estimate of $-0.07.
The Actual Revenue was $11.6M, which missed the estimate of $13.5M.
Browse earnings estimates, EPS, and revenue on all stocks.